Neuroprotection by dehydroepiandrosteronesulfate: role of an NFκB-like factor

    loading  Checking for direct PDF access through Ovid

Abstract

LEVELS of dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEA-S) decline during aging and reach even lower levels in Alzheimer's disease (AD). Previously published effects of DHEA and DHEA-S on unchallenged neuronal survival led us to test them in an excitotoxicity paradigm. While DHEA-S protected hippocampal neurons against glutamate, little protection was observed with equivalent doses of DHEA itself. This differential neuroprotection was consistent with the ability of DHEA-S (but not DHEA) to elevate a κB-dependent transcription factor activity, a phenomenon we previously have connected with neuroprotection. Furthermore, suppression o fκB DNA-binding by ‘decoy’ oligonucleotides blocked the neuroprotective activity of DHEA-S. These findings imply that age-related declines in the availability of DHEA-S could exacerbate neurotoxicity, and the data suggest that therapeutic gains may be obtained with pharmacological manipulation o fκB-dependent transcription in neurons.

Related Topics

    loading  Loading Related Articles